CRT 2016 Coronary - Antiplatelet Controversies for ACS: How Will They Impact Our Practice?

Conference
Antiplatelet Controversies for ACS: 'How Will They Impact Our Practice?' at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

CRT 2016 - Antiplatelet Controversies for ACS: 'How Will They Impact Our Practice?' Session

Session Moderators & Panelists: C. Michael Gibson, MD; Paul Gurbel, MD, FSCAI; Ron Waksman, MD, FSCAI; Duane Pinto, MD, MPH, FSCAI

11 Expert Sessions

Featuring

  • C. Michael Gibson, MD
  • Paul Gurbel, MD, FSCAI
  • Ron Waksman, MD, FSCAI
  • Duane Pinto, MD, MPH, FSCAI
  • Jeffrey Berger, MD, MS
  • Dominick Angiolillo, MD, PhD, FSCAI
  • David Cox, MD, FSCAI
  • Gary Schaer, MD, FSCAI
  • Michael Lipinski, MD, PhD, FSCAI
  • David Cohen, MD, FSCAI
  • Ori Ben-Yehuda, MD
  • Roxana Mehran, MD, FACC, FSCAI
  • Neal Kleiman, MD, FSCAI

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.



Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: Antiplatelet Controversies for ACS: How Will They Impact Our Practice?

Track: Coronary

Learning Objectives

  • Update in advances in ACS & AMI Management

Loading Simple Education